Reviewing Minerva Surgical (NASDAQ:UTRS) and Acutus Medical (NASDAQ:AFIB)

Institutional and Insider Ownership

56.9% of Acutus Medical shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Minerva Surgical and Acutus Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Minerva Surgical	$51.69 million	0.00	-$34.11 million	($8.21)	N/A
Acutus Medical	$7.16 million	0.18	-$81.66 million	N/A	N/A

Minerva Surgical has higher revenue and earnings than Acutus Medical.

Profitability

This table compares Minerva Surgical and Acutus Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Minerva Surgical	N/A	N/A	N/A
Acutus Medical	-272.74%	-311.64%	-11.57%

Volatility and Risk

Minerva Surgical has a beta of 3.96, meaning that its share price is 296% more volatile than the S&P 500. Comparatively, Acutus Medical has a beta of -0.22, meaning that its share price is 122% less volatile than the S&P 500.

Summary

Minerva Surgical beats Acutus Medical on 7 of the 8 factors compared between the two stocks.

About Minerva Surgical

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

About Acutus Medical

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.